Bioelectronics Corp (BIEL)

[Simpsonly]

It would seem that BIEL management may have learned its lesson, to sit patiently and quietly while the FDA goes through its approval processes. Better than the CEO apparently allowing himself to be manipulated by the press, TV and others into making nutty statements like next week, next month and next quarter, don't you think?

The rest of BIEL probably told him to sit in his office, turn the lights off, unplug the phone and be silent and be still. I suggested a while ago, in hindsight I know, that he should have kept his comments to a hopeful and expectant, absolute minimum, without giving timeframes. Maybe they listened?

Meanwhile we sit patiently waiting for decisions on ActiPatch and ALLAY but I think, personally, there should be no impediment to FDA approvals because no one has come up with one single adverse side-effect caused by the already approved RecoveryRx technology or any other reason.